James Condulis
Stock Analyst at Stifel
(2.83)
# 1,577
Out of 5,038 analysts
7
Total ratings
66.67%
Success rate
25.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $24 | $10.97 | +118.78% | 1 | Sep 29, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $54.76 | +75.31% | 2 | Sep 2, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $35.00 | +25.71% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $66.90 | +61.43% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $14.89 | +101.48% | 1 | Jan 22, 2025 |
Aardvark Therapeutics
Sep 29, 2025
Initiates: Buy
Price Target: $24
Current: $10.97
Upside: +118.78%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $54.76
Upside: +75.31%
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $35.00
Upside: +25.71%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $66.90
Upside: +61.43%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $14.89
Upside: +101.48%